1. Anticancer Specificity of Some Ellipticinium Salts against Human Brain Tumors in vitro
2. (1995): Generation of a drug resistance profile by quantitation of mdr-1/P-glycoprotein expression in the cell lines of the NCI anticancer drug screen. J Clin Invest (in press).
3. (1986): National Cancer Institute drug discovery and development. In (eds): Accomplishments in Oncology, Vol 1, Cancer Therapy: Where Do We Go From Here? Philadelphia: JB Lippincott, pp 68-76.